These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peptide radiopharmaceuticals for diagnosis and therapy. Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500 [TBL] [Abstract][Full Text] [Related]
3. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Okarvi SM Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368 [TBL] [Abstract][Full Text] [Related]
4. Current status of radionuclide tracer imaging of thrombi and atheroma. Cerqueira MD Semin Nucl Med; 1999 Oct; 29(4):339-51. PubMed ID: 10534236 [TBL] [Abstract][Full Text] [Related]
5. Radiolabeled peptides in diagnosis and therapy. Weiner RE; Thakur ML Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772 [TBL] [Abstract][Full Text] [Related]
6. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides come of age. Miller L J Nucl Med; 1993 Nov; 34(11):15N, 18N, 27N-30N. PubMed ID: 7901351 [No Abstract] [Full Text] [Related]
9. Rationale for the use of radiolabelled peptides in diagnosis and therapy. Koopmans KP; Glaudemans AW Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630 [TBL] [Abstract][Full Text] [Related]
10. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases. Tornesello AL; Tornesello ML; Buonaguro FM Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023 [TBL] [Abstract][Full Text] [Related]
11. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases. Sosabowsky J; Melendez-Alafort L; Mather S Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415 [TBL] [Abstract][Full Text] [Related]
13. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview. Okarvi SM Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991 [TBL] [Abstract][Full Text] [Related]
14. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation. van Eerd JE; Boerman OC; Corstens FH; Oyen WJ Q J Nucl Med; 2003 Dec; 47(4):246-55. PubMed ID: 14973417 [TBL] [Abstract][Full Text] [Related]
15. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction. van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van der Meer JW; Corstens FH Eur J Nucl Med; 1998 May; 25(5):535-46. PubMed ID: 9575251 [TBL] [Abstract][Full Text] [Related]
16. Radiopharmaceuticals for the study of inflammatory processes: a review. Chianelli M; Mather SJ; Martin-Comin J; Signore A Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086 [TBL] [Abstract][Full Text] [Related]